DUAL TARGETING OF MDMX AND MDM2 HAS ANTILEUKEMIC ACTIVITY

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2018年 / 8卷 / 06期
关键词：
D O I：
10.1158/2159-8290.CD-RW2018-068
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [21] Mdm2 and MdmX: Partners in p53 Destruction
    Manfredi, James J.
    CANCER RESEARCH, 2021, 81 (07) : 1633 - 1634
  • [22] MDM2/MDMX inhibitor peptide: WO2008106507
    Macchiarulo, Antonio
    Pellicciari, Roberto
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (05) : 721 - 726
  • [23] MDM2 interacts with MDMX through their RING finger domains
    Tanimura, S
    Ohtsuka, S
    Mitsui, K
    Shirouzu, K
    Yoshimura, A
    Ohtsubo, M
    FEBS LETTERS, 1999, 447 (01) : 5 - 9
  • [24] Mdm2 and MdmX partner to regulate p53
    Wang, Xinjiang
    Jiang, Xuejun
    FEBS LETTERS, 2012, 586 (10) : 1390 - 1396
  • [25] Regulation of p63 function by Mdm2 and MdmX
    Kadakia, M
    Slader, C
    Berberich, SJ
    DNA AND CELL BIOLOGY, 2001, 20 (06) : 321 - 330
  • [26] Targeting the Conformational Transitions of MDM2 and MDMX: Insights into Dissimilarities and Similarities of p53 Recognition
    Macchiarulo, Antonio
    Giacche, Nicola
    Carotti, Andrea
    Baroni, Massimo
    Cruciani, Gabriele
    Pellicciari, Roberto
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (10) : 1999 - 2009
  • [27] Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
    Macchiarulo, Antonio
    Giacche, Nicola
    Carotti, Andrea
    Moretti, Fabiola
    Pellicciari, Roberto
    MEDCHEMCOMM, 2011, 2 (06) : 455 - 465
  • [28] Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation
    Xia, Mingxuan
    Knezevic, Dejan
    Tovar, Christian
    Huang, Baoying
    Heimbrook, David C.
    Vassilev, Lyubomir T.
    CELL CYCLE, 2008, 7 (11) : 1604 - 1612
  • [29] Gossypol has anti-cancer effects by dual targeting MDM2 and VEGF in human breast cancer
    Xiong, Jing
    Li, Jiansha
    Yang, Qin
    Wang, Jun
    Su, Tiefen
    Zhou, Sheng
    BREAST CANCER RESEARCH, 2017, 19
  • [30] MDM2 and MDMX status as a determinant of in vitro cellular sensitivity to MDM2 antagonists in human tumour cell lines
    Lu, X.
    Liu, J.
    Watson, A.
    Hardcastle, I. R.
    Griffin, R. J.
    Golding, B. T.
    Newell, D. R.
    Lunec, J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 137 - 137
12345